Comparison of the efficacy of one, two, and third doses of BNT162b2 in patients suffering from cardiovascular diseases, respiratory diseases, and diabetes against COVID-19
The COVID-19 pandemic has had a major impact on human health around the world. Given the speed of the spread of the disease and its impact on people’s lives, different countries including Jordan issued approval for the emergency use of the mRNA vaccine BNT162b2 for COVID-19. This respiratory disease...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pensoft Publishers
2023-02-01
|
| Series: | Pharmacia |
| Online Access: | https://pharmacia.pensoft.net/article/97777/download/pdf/ |